Patents by Inventor Hannah Burgess

Hannah Burgess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting RNA viruses using inhibitors of METTL3
    Patent number: 11944608
    Abstract: Provided are methods for prophylaxis or therapy for an RNA virus infection. The methods involve modulating the Type I interferon pathway in RNA virus infected cells of an individual. The Type I interferon pathway is modulated by administering one or more agents to virus infected cells that inhibit the expression and/or function of METTL3 or inhibit expression and/or function of YTHDF1, YTHDF2 or YTHDF3.
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: April 2, 2024
    Assignee: NEW YORK UNIVERSITY
    Inventors: Ian Mohr, Hannah Burgess, Angus Wilson
  • TARGETING RNA VIRUSES USING INHIBITORS OF METTL3
    Publication number: 20220125768
    Abstract: Provided are methods for prophylaxis or therapy for an RNA virus infection. The methods involve modulating the Type I interferon pathway in RNA virus infected cells of an individual. The Type I interferon pathway is modulated by administering one or more agents to virus infected cells that inhibit the expression and/or function of METTL3 or inhibit expression and/or function of YTHDF1, YTHDF2 or YTHDF3.
    Type: Application
    Filed: October 26, 2021
    Publication date: April 28, 2022
    Inventors: Ian Mohr, Hannah Burgess, Angus Wilson